Carbon Fiber Reinforced PEEK for Medical Implants
Vestakeep is available at two levels of carbon fiber content and appropriate for long-term surgical implants.
Evonik is introducing a new carbon-fiber reinforced polyetheretherketone (PEEK) filament, for use in 3D printed medical implants. It be processed in common extrusion-based 3D printing technologies such as fused filament fabrication (FFF).
Vestakeep iC4612 and Vestakeep iC4620 feature 12% and 20% carbon fiber content, respectively. The two grades offer a choice of material depending on the required strength and flex properties of 3D printed implants such as bone plates and other reconstructive prostheses.
Carbon fiber reinforced PEEK filament for printing long term surgical implants. Photo Credit: Evonik
Carbon fibers add strength to the filament products, while PEEK adds ductility. Other benefits, according to Evonik, include the ability to define the alignment of carbon fibers during the printing process, biocompatibility and avoiding X-ray artifacts.
With a diameter of 1.75 mm, Vestakeep iC4612 and iC4620 are supplied on 500 g and 1,000 g spools that can be used directly in standard FFF/FDM 3D printers for PEEK materials.
“No other application field showcases more the advantages of 3D printing, such as individualization or design freedom, than medical technology,” says Marc Knebel, head of medical systems at Evonik. “In trauma applications, for instance, 3D printed solutions offer an enormous time advantage over traditionally manufactured medical devices. It is conceivable that patient-specific solutions can be manufactured within two or three days, significantly improving the recovery phase.”
Related Content
-
Volume Resin Prices Move in Different Directions
PE, PP, PVC, and ABS prices slump, while PS, PET, PC, and nylons 6 and 66 prices rise.
-
Tracing the History of Polymeric Materials: Acetal
The road from discovery in the lab to commercial viability can be long, and this was certainly the case for acetal polymers.
-
Prices of Volume Resins Drop
Price relief is expected to continue through the fourth quarter for nine major commodity and engineering resins, driven by widespread supply/demand imbalances.